{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:29:02Z","timestamp":1776918542857,"version":"3.51.2"},"reference-count":44,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0451","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T17:33:42Z","timestamp":1551202422000},"page":"409-422","source":"Crossref","is-referenced-by-count":10,"title":["Serum autotaxin levels are associated with Graves\u2019 disease"],"prefix":"10.1507","volume":"66","author":[{"given":"Takahiro","family":"Nojiri","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan"},{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan"},{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Gunma, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nakawatari","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shimamoto","sequence":"additional","affiliation":[{"name":"Bioscience Division, TOSOH Corporation, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Bioscience Division, TOSOH Corporation, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniyuki","family":"Kano","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Miyagi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Miyagi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Murakami","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Miyagi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan"},{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Smith TJ, Hegedus L (2016) Graves\u2019 Disease. N Engl J Med 375: 1552\u20131565.","DOI":"10.1056\/NEJMra1510030"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, et al. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158: 227\u2013233.","DOI":"10.1083\/jcb.200204026"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, et al. (2007) Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 41: 616\u2013623.","DOI":"10.1097\/01.mcg.0000225642.90898.0e"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Nakagawa H, Ikeda H, Nakamura K, Ohkawa R, Masuzaki R, et al. (2011) Autotaxin as a novel serum marker of liver fibrosis. Clin Chim Acta 412: 1201\u20131206.","DOI":"10.1016\/j.cca.2011.03.014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ikeda H, Kobayashi M, Kumada H, Enooku K, Koike K, et al. (2018) Performance of autotaxin as a serum marker for liver fibrosis. Ann Clin Biochem 55: 469\u2013477.","DOI":"10.1177\/0004563217741509"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Masuda A, Fujii T, Iwasawa Y, Nakamura K, Ohkawa R, et al. (2011) Serum autotaxin measurements in pregnant women: application for the differentiation of normal pregnancy and pregnancy-induced hypertension. Clin Chim Acta 412: 1944\u20131950.","DOI":"10.1016\/j.cca.2011.06.039"},{"key":"7","unstructured":"7 Kawagoe H, Stracke ML, Nakamura H, Sano K (1997) Expression and transcriptional regulation of the PD-Ialpha\/autotaxin gene in neuroblastoma. Cancer Res 57: 2516\u20132521."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Yang SY, Lee J, Park CG, Kim S, Hong S, et al. (2002) Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis 19: 603\u2013608.","DOI":"10.1023\/A:1020950420196"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, et al. (2008) Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol 143: 60\u201370.","DOI":"10.1111\/j.1365-2141.2008.07325.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Miyabe Y, Miyabe C, Iwai Y, Takayasu A, Fukuda S, et al. (2013) Necessity of lysophosphatidic acid receptor 1 for development of arthritis. Arthritis Rheum 65: 2037\u20132047.","DOI":"10.1002\/art.37991"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Orosa B, Garcia S, Conde C (2015) The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis. Eur J Pharmacol 765: 228\u2013233.","DOI":"10.1016\/j.ejphar.2015.08.028"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Thirunavukkarasu K, Tan B, Swearingen CA, Rocha G, Bui HH, et al. (2016) Pharmacological characterization of a potent inhibitor of autotaxin in animal models of inflammatory bowel disease and multiple sclerosis. J Pharmacol Exp Ther 359: 207\u2013214.","DOI":"10.1124\/jpet.116.234013"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Georas SN (2009) Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity. Immunol Res 45: 229\u2013238.","DOI":"10.1007\/s12026-009-8104-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kanda H, Newton R, Klein R, Morita Y, Gunn MD, et al. (2008) Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 9: 415\u2013423.","DOI":"10.1038\/ni1573"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Zhang Y, Chen YC, Krummel MF, Rosen SD (2012) Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells. J Immunol 189: 3914\u20133924.","DOI":"10.4049\/jimmunol.1201604"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Rosskopf D, Daelman W, Busch S, Schurks M, Hartung K, et al. (1998) Growth factor-like action of lysophosphatidic acid on human B lymphoblasts. Am J Physiol 274: C1573\u2013C1582.","DOI":"10.1152\/ajpcell.1998.274.6.C1573"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Mu H, Calderone TL, Davies MA, Prieto VG, Wang H, et al. (2012) Lysophosphatidic acid induces lymphangiogenesis and IL-8 production <i>in vitro<\/i> in human lymphatic endothelial cells. Am J Pathol 180: 2170\u20132181.","DOI":"10.1016\/j.ajpath.2012.03.003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Sun Y, Zhang W, Evans JF, Floreani A, Zou Z, et al. (2016) Autotaxin, pruritus and primary biliary cholangitis (PBC). Autoimmun Rev 15: 795\u2013800.","DOI":"10.1016\/j.autrev.2016.03.019"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Lee HY, Murata J, Clair T, Polymeropoulos MH, Torres R, et al. (1996) Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun 218: 714\u2013719.","DOI":"10.1006\/bbrc.1996.0127"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hashimoto T, Okudaira S, Igarashi K, Hama K, Yatomi Y, et al. (2012) Identification and biochemical characterization of a novel autotaxin isoform, ATXdelta, with a four-amino acid deletion. J Biochem 151: 89\u201397.","DOI":"10.1093\/jb\/mvr126"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Nakamura K, Igarashi K, Ide K, Ohkawa R, Okubo S, et al. (2008) Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 388: 51\u201358.","DOI":"10.1016\/j.cca.2007.10.005"},{"key":"22","unstructured":"22 Tokuhara Y, Kurano M, Shimamoto S, Igarashi K, Nojiri T, et al. (2015) A new enzyme immunoassay for the quantitative determination of classical autotaxins (ATXalpha, ATXbeta, and ATXgamma) and novel autotaxins (ATXdelta and ATXepsilon). PLoS One 10: e0130074."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Takahashi C, Kurano M, Nishikawa M, Kano K, Dohi T, et al. (2017) Vehicle-dependent effects of sphingosine 1-phosphate on plasminogen activator inhibitor-1 expression. J Atheroscler Thromb 24: 954\u2013969.","DOI":"10.5551\/jat.37663"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Adams AC, Astapova I, Fisher FM, Badman MK, Kurgansky KE, et al. (2010) Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner. J Biol Chem 285: 14078\u201314082.","DOI":"10.1074\/jbc.C110.107375"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Nakasaki T, Tanaka T, Okudaira S, Hirosawa M, Umemoto E, et al. (2008) Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am J Pathol 173: 1566\u20131576.","DOI":"10.2353\/ajpath.2008.071153"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Okudaira M, Inoue A, Shuto A, Nakanaga K, Kano K, et al. (2014) Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS\/MS. J Lipid Res 55: 2178\u20132192.","DOI":"10.1194\/jlr.D048439"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ferry G, Tellier E, Try A, Gres S, Naime I, et al. (2003) Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem 278: 18162\u201318169.","DOI":"10.1074\/jbc.M301158200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Jiang W, Miyamoto T, Kakizawa T, Sakuma T, Nishio S, et al. (2004) Expression of thyroid hormone receptor alpha in 3T3-L1 adipocytes; triiodothyronine increases the expression of lipogenic enzyme and triglyceride accumulation. J Endocrinol 182: 295\u2013302.","DOI":"10.1677\/joe.0.1820295"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Benesch MG, Ko YM, Tang X, Dewald J, Lopez-Campistrous A, et al. (2015) Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer. Endocr Relat Cancer 22: 593\u2013607.","DOI":"10.1530\/ERC-15-0045"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Nakamura K, Takeuchi T, Ohkawa R, Okubo S, Yokota H, et al. (2007) Serum lysophospholipase D\/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients. Ann Clin Biochem 44: 549\u2013556.","DOI":"10.1258\/000456307782268147"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Siess W, Tigyi G (2004) Thrombogenic and atherogenic activities of lysophosphatidic acid. J Cell Biochem 92: 1086\u20131094.","DOI":"10.1002\/jcb.20108"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32 Haseruck N, Erl W, Pandey D, Tigyi G, Ohlmann P, et al. (2004) The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 103: 2585\u20132592.","DOI":"10.1182\/blood-2003-04-1127"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Tigyi G (2001) Physiological responses to lysophosphatidic acid and related glycero-phospholipids. Prostaglandins Other Lipid Mediat 64: 47\u201362.","DOI":"10.1016\/S0090-6980(01)00107-1"},{"key":"34","unstructured":"34 Rizza C, Leitinger N, Yue J, Fischer DJ, Wang DA, et al. (1999) Lysophosphatidic acid as a regulator of endothelial\/leukocyte interaction. Lab Invest 79: 1227\u20131235."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Lin CI, Chen CN, Lin PW, Chang KJ, Hsieh FJ, et al. (2007) Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3. Biochem Biophys Res Commun 363: 1001\u20131008.","DOI":"10.1016\/j.bbrc.2007.09.081"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Aikawa S, Hashimoto T, Kano K, Aoki J (2015) Lysophosphatidic acid as a lipid mediator with multiple biological actions. J Biochem 157: 81\u201389.","DOI":"10.1093\/jb\/mvu077"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Panther E, Idzko M, Corinti S, Ferrari D, Herouy Y, et al. (2002) The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 169: 4129\u20134135.","DOI":"10.4049\/jimmunol.169.8.4129"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Rubenfeld J, Guo J, Sookrung N, Chen R, Chaicumpa W, et al. (2006) Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells. Am J Physiol Lung Cell Mol Physiol 290: L66\u2013L74.","DOI":"10.1152\/ajplung.00473.2004"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Kurano M, Kano K, Dohi T, Matsumoto H, Igarashi K, et al. (2017) Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome. J Lipid Res 58: 433\u2013442.","DOI":"10.1194\/jlr.P071803"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Kurano M, Miyagaki T, Miyagawa T, Igarashi K, Shimamoto S, et al. (2018) Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma. J Dermatol 45: 571\u2013579.","DOI":"10.1111\/1346-8138.14278"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Emoto S, Kurano M, Kano K, Matsusaki K, Yamashita H, et al. (2017) Analysis of glycero-lysophospholipids in gastric cancerous ascites. J Lipid Res 58: 763\u2013771.","DOI":"10.1194\/jlr.P072090"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Nakamura K, Kishimoto T, Ohkawa R, Okubo S, Tozuka M, et al. (2007) Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma <i>in vitro<\/i>: proposal of a plasma sample preparation method for laboratory testing of these lipids. Anal Biochem 367: 20\u201327.","DOI":"10.1016\/j.ab.2007.05.004"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Hosogaya S, Yatomi Y, Nakamura K, Ohkawa R, Okubo S, et al. (2008) Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity. Ann Clin Biochem 45: 364\u2013368.","DOI":"10.1258\/acb.2008.007242"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Mullin BR, Fishman PH, Lee G, Aloj SM, Ledley FD, et al. (1976) Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc Natl Acad Sci U S A 73: 842\u2013846.","DOI":"10.1073\/pnas.73.3.842"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/5\/66_EJ18-0451\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:27:42Z","timestamp":1559345262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/5\/66_EJ18-0451\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0451","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}